Filing Details
- Accession Number:
- 0000950170-25-003153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-07 19:57:18
- Reporting Period:
- 2025-01-03
- Accepted Time:
- 2025-01-07 19:57:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1880438 | An2 Therapeutics Inc. | ANTX | Pharmaceutical Preparations (2834) | 820606654 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2042268 | David Stephen Prior | C/O An2 Therapeutics, Inc. 1800 El Camino Real, Suite D Menlo Park CA 94027 | Chief Strategy Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-03 | 2,029 | $1.34 | 33,313 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
- Includes (a) 10,125 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 and (b) 12,031 RSUs which shall vest on January 1, 2026, in each case, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.
Billionaire Hedge Funds
